BAM
BIIB icon

Blueshift Asset Management’s Biogen BIIB Stock Holding History

Blueshift Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,099
Closed -$311K – 860
2021
Q3 		$311K Buy
+1,099
New +$360K 0.02% 796
2019
Q2 		– Sell
-882
Closed -$208K – 717
2019
Q1 		$208K Buy
+882
New +$278K 0.03% 616

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Blueshift Asset Management's BIIB Position: Q4 2021 in Review

Blueshift Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 1,099 shares — an estimated $311K sold.

Blueshift Asset Management first reported a position in BIIB in Q1 2019 and held it in 2 quarters. The position peaked at $311K in Q3 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Blueshift Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 1,099 Biogen shares in Q4 2021, an estimated $311K.
  • Blueshift Asset Management first reported a position in Biogen in Q1 2019 and held it in 2 quarters.
  • Blueshift Asset Management's Biogen position peaked at $311K in Q3 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.